Comparison of minimum effective concentration of mepivacaine for axillary block in patients with/ without diabetic neuropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005715

Enrollment

Registered

2020-12-29

Start date

2020-12-31

Completion date

Unknown

Last updated

2021-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Ultrasound-guided axillary block was performed with different concentrations of mepivacaine 30 mL.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients without diabetic neuropathy scheduled for upper extremitu surgery patients with diabetic neuropathy scheduled for AV fistula formation and/or repair.

Exclusion criteria

Exclusion criteria: conraindication to regional anesthesia allergy to amide loal anesthetics neurological deficits in the operated extremity pregnanacy inabilty tounderstand study

Design outcomes

Primary

Measure	Time frame
block success and failure (50% minimum effective concentration of mepivacaine)	—

Secondary

Measure	Time frame
the minimal intensity of nerve stimulation for the musculocutaneous nerve;complications (vascular puncture, paresthesia, and local anesthetic toxicity);use of supplemental analgesia or conversion to general anesthesia	—

Countries

Korea, Republic of

Contacts

Public ContactChunwoo Yang

Inha University Hospital

everycw@daum.net+82-32-890-3968

Outcome results